Drug Profile
Teriparatide biosimilar - Biosidus
Alternative Names: Osteofortil; Recombinant teriparatide - BiosidusLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Biosidus S.A.
- Class Diagnostic agents; Osteoporosis therapies; Peptide hormones; Skin disorder therapies
- Mechanism of Action Parathyroid hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Osteoporosis
Most Recent Events
- 30 Sep 2012 Launched for Osteoporosis in Argentina (Parenteral)